Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Report 2026

Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview

• Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring market size has reached to $1.69 billion in 2025 • Expected to grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 21.3% • Growth Driver: Expansion Of Telehealth Services Driving The Market Growth Due To Increasing Remote Patient Care Needs • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?

Artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring is a system that uses AI algorithms to continuously track and analyze IV therapy data in real time. It can detect irregularities, predict complications, and optimize fluid or medication delivery based on patient-specific patterns. The technology integrates sensors, data analytics, and automated alerts to improve safety and efficiency in IV treatment management. The main components of artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring are hardware, software, and services. Hardware consists of the tangible equipment and devices that collect, process, and support system functions, such as infusion pumps and wearable monitors for patient care. These systems are deployed on-premises or cloud-based. They are used for various applications, including hospitals, clinics, homecare settings, ambulatory surgical centers, and others, and are used by various end-users, including healthcare providers and patients.

What Is The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Growth Forecast?

The artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market size is expected to see exponential growth in the next few years. It will grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled infusion monitoring, rising demand for home-based iv therapy solutions, expansion of predictive patient safety analytics, growing integration of connected infusion systems, increasing emphasis on remote clinical monitoring. Major trends in the forecast period include increasing adoption of real-time iv flow analytics, rising use of AI-based infusion error detection, growing integration of smart infusion sensors, expansion of remote iv therapy management, enhanced focus on patient safety and compliance.

Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Segmentation

1) By Component: Hardware, Software, Services 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, Other Applications 4) By End-User: Healthcare Providers, Patients Subsegments: 1) By Hardware: Patient Monitoring Devices, Sensors And Infusion Pumps, Communication Devices, Data Storage Systems 2) By Software: Predictive Analytics Software, Clinical Decision Support Software, Remote Monitoring Software, Data Management Software 3) By Services: Implementation And Integration Services, Maintenance And Support Services, Training And Education Services, Remote Monitoring Services

What Are The Drivers Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?

The expansion of telehealth services is expected to propel the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market going forward. Telehealth services are healthcare delivery methods that utilize digital communication technologies to provide medical consultations, monitoring, and treatment remotely. Telehealth has expanded due to regulatory changes and reimbursement policies implemented during the COVID-19 pandemic, making virtual healthcare more accessible and financially viable for both providers and patients. Artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring supports telehealth services by enabling real-time, remote tracking of patients’ IV therapy, automatically detecting complications, providing actionable insights to healthcare providers, and seamlessly integrating with virtual care platforms to ensure timely interventions, improved patient safety, and more efficient management of home-based and outpatient treatments. For instance, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, in 2023, national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the expansion of telehealth services is driving the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry. The proliferation of wearable health technologies is expected to propel the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market going forward. Wearable health technologies refer to devices such as smartwatches and fitness trackers that monitor various health metrics in real time. The adoption of wearable health technologies is rising due to increasing health awareness because more people are actively monitoring their health, tracking vital signs, and seeking tools that provide real-time insights into their well-being. The adoption of wearable health technologies supports remote patient intravenous (IV) monitoring by continuously collecting real-time physiological data from patients, which can be analyzed to detect anomalies, optimize IV treatment, and enable timely, personalized interventions without requiring constant in-person supervision. For instance, in April 2025, according to the UK Parliament's House of Commons Library, a UK-based government administration, between 2023 and 2024, the NIHR and UKRI invested approximately USD 15 million (£11.5 million) in 10 research projects focused on developing wearable technologies to support greater independence for people living with frailty or long-term physical disabilities. Therefore, the proliferation of wearable health technologies is driving the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry. The increasing healthcare expenditure is expected to propel the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services and products within a specific period. The healthcare expenditure is rising due to the growing demand for advanced medical technologies and services to improve patient outcomes, enhance treatment efficiency, and support the adoption of AI-enhanced remote patient monitoring. Growing healthcare expenditure supports AI-enhanced remote patient IV monitoring by funding advanced technologies, digital infrastructure, and staff training for more efficient and accurate patient care. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services, a US-based government agency, in 2023, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion, averaging $14,570 per person and representing 17.6% of the Gross Domestic Product (GDP). Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of total NHE. Therefore, increasing healthcare expenditure is driving the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry.

Key Players In The Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

Major companies operating in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.

Regional Outlook

North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market consists of revenues earned by entities by providing services such as continuous IV flow monitoring, AI-powered predictive analytics, remote patient monitoring, automated alerts and notifications, data management and reporting, telehealth integration, device management and support, and medication management support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market also includes sales of flow meters, pressure transducers, wireless control interfaces for infusion pumps, cloud-integrated drug infusion systems, and AI-enhanced remote monitoring platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Report 2026?

The artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.